menu
    • menu

    Company profile for Cardiff Oncology

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clini...
    At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cardiff OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11055 Flintkote Avenue San Diego, CA 92121
    Telephone
    Telephone
    +1 858-952-7570
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cardiffoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiff Oncology Releases 2025 Results And Business Update
    Cardiff Oncology Releases 2025 Results And Business Update

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3244087/0/en/Cardiff-Oncology-Reports-Full-Year-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Cardiff Oncology Presents at 36th Oppenheimer Healthcare Conf
    Cardiff Oncology Presents at 36th Oppenheimer Healthcare Conf

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240928/0/en/Cardiff-Oncology-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Cardiff Churns C-suite to Advance Cancer Candidate
    Cardiff Churns C-suite to Advance Cancer Candidate

    30 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chutes-ladders-cardiff-churns-c-suite-advance-cancer-candidate

    FIERCE BIOTECH
    30 Jan 2026
    Share Share
    Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data
    Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data

    28 Jan 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/cardiff-craters-amid-executive-exits-mixed-mid-stage-data

    BIOSPACE
    28 Jan 2026
    Share Share
    Cardiff Oncology Announces Executive Leadership Changes
    Cardiff Oncology Announces Executive Leadership Changes

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226332/0/en/Cardiff-Oncology-Announces-Executive-Leadership-Changes-as-it-Transitions-to-Late-Stage-Clinical-Development.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Cardiff Oncology Reports Positive Phase 2 Onvansertib Data
    Cardiff Oncology Reports Positive Phase 2 Onvansertib Data

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226345/0/en/Cardiff-Oncology-Announces-Positive-Update-from-its-Randomized-Phase-2-Trial-of-Onvansertib-in-First-line-RAS-mutated-mCRC.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search